Task Force 1: The ACCF and AHA codes of conduct in human subjects research
Patients who participate in clinical trials, whether they receive experimental treatment or if they are in a control group, can benefit from meticulous attention to their care, by learning more about their disease process, and potentially, from the trial environment itself (6). Because results of re...
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2004-10, Vol.44 (8), p.1724-1728 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1728 |
|---|---|
| container_issue | 8 |
| container_start_page | 1724 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 44 |
| creator | Alpert, Joseph S. Shine, Kenneth I. Adams, Robert J. Antman, Elliott M. Kavey, Rae Ellen W. Friedman, Lawrence Frye, Robert L. Harrington, Robert A. Korn, David Merz, Jon F. Ofili, Elizabeth |
| description | Patients who participate in clinical trials, whether they receive experimental treatment or if they are in a control group, can benefit from meticulous attention to their care, by learning more about their disease process, and potentially, from the trial environment itself (6). Because results of research usually apply more directly to those patient groups included in the studies, it is especially important to include subjects from all socio-economic strata and all ethnic groups. In this setting, the potential for influence by factors unrelated to the best interest of the child, such as payment for participation, can significantly impact parental decision-making. [...]pediatric researchers are particularly obligated to strive for informed consent to the greatest extent possible. |
| doi_str_mv | 10.1016/j.jacc.2004.08.038 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66979511</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109704017139</els_id><sourcerecordid>3242521401</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-e63197221c98b1709a6c285083103abd757dfa9167c08f1d4f743bdc33eccc4f3</originalsourceid><addsrcrecordid>eNp9kEGL1EAQhRtR3HH1D3iQBsFbYlU6ne4WL8PguCsLXsZz06muMIkzydo9Efz3ZpgBwcOe6h2-9yg-Id4ilAjYfBzKIRCVFUBdgi1B2WdihVrbQmlnnosVGKULBGduxKucBwBoLLqX4gZ1bR2iXolvu5B_yu2UiCV-krs9y_Vms5VhjHJ9t5Y0Rc5y6pYwxplOsh_lfj6GUea5HZhOWSbOHBLtX4sXXThkfnO9t-LH9stuc1c8fP96v1k_FKQsnApuFDpTVUjOtmjAhYYqq8EqBBXaaLSJXXDYGALbYaw7U6s2klJMRHWnbsWHy-5jmn7NnE_-2GfiwyGMPM3ZN40zTiMu4Pv_wGGa07j85lFDg3oxd6aqC0Vpyjlx5x9Tfwzpj0fwZ89-8GfP_uzZg_WL56X07jo9t0eO_ypXsQvw-QLwYuJ3z8ln6nkkjn1arPk49U_t_wW-T4q5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1506152001</pqid></control><display><type>article</type><title>Task Force 1: The ACCF and AHA codes of conduct in human subjects research</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ScienceDirect Journals (5 years ago - present)</source><source>Alma/SFX Local Collection</source><creator>Alpert, Joseph S. ; Shine, Kenneth I. ; Adams, Robert J. ; Antman, Elliott M. ; Kavey, Rae Ellen W. ; Friedman, Lawrence ; Frye, Robert L. ; Harrington, Robert A. ; Korn, David ; Merz, Jon F. ; Ofili, Elizabeth</creator><creatorcontrib>Alpert, Joseph S. ; Shine, Kenneth I. ; Adams, Robert J. ; Antman, Elliott M. ; Kavey, Rae Ellen W. ; Friedman, Lawrence ; Frye, Robert L. ; Harrington, Robert A. ; Korn, David ; Merz, Jon F. ; Ofili, Elizabeth</creatorcontrib><description>Patients who participate in clinical trials, whether they receive experimental treatment or if they are in a control group, can benefit from meticulous attention to their care, by learning more about their disease process, and potentially, from the trial environment itself (6). Because results of research usually apply more directly to those patient groups included in the studies, it is especially important to include subjects from all socio-economic strata and all ethnic groups. In this setting, the potential for influence by factors unrelated to the best interest of the child, such as payment for participation, can significantly impact parental decision-making. [...]pediatric researchers are particularly obligated to strive for informed consent to the greatest extent possible.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2004.08.038</identifier><identifier>PMID: 15489115</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Advisory Committees ; Bioethics ; Cardiology ; Cardiovascular Diseases - therapy ; Clinical trials ; Clinical Trials as Topic - legislation & jurisprudence ; Codes ; Conflict of Interest - legislation & jurisprudence ; Ethics, Medical ; Human Experimentation - legislation & jurisprudence ; Human subjects ; Humans ; Informed consent ; Informed Consent - legislation & jurisprudence ; Mental Competency - legislation & jurisprudence ; Participation ; Pediatrics ; Pharmaceutical industry ; Research Design ; Societies, Medical ; Studies ; Task forces ; United States</subject><ispartof>Journal of the American College of Cardiology, 2004-10, Vol.44 (8), p.1724-1728</ispartof><rights>2004 American College of Cardiology Foundation and the American Heart Association, Inc.</rights><rights>Copyright Elsevier Limited Oct 19, 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-e63197221c98b1709a6c285083103abd757dfa9167c08f1d4f743bdc33eccc4f3</citedby><cites>FETCH-LOGICAL-c380t-e63197221c98b1709a6c285083103abd757dfa9167c08f1d4f743bdc33eccc4f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jacc.2004.08.038$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,778,782,3539,27911,27912,45982</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15489115$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alpert, Joseph S.</creatorcontrib><creatorcontrib>Shine, Kenneth I.</creatorcontrib><creatorcontrib>Adams, Robert J.</creatorcontrib><creatorcontrib>Antman, Elliott M.</creatorcontrib><creatorcontrib>Kavey, Rae Ellen W.</creatorcontrib><creatorcontrib>Friedman, Lawrence</creatorcontrib><creatorcontrib>Frye, Robert L.</creatorcontrib><creatorcontrib>Harrington, Robert A.</creatorcontrib><creatorcontrib>Korn, David</creatorcontrib><creatorcontrib>Merz, Jon F.</creatorcontrib><creatorcontrib>Ofili, Elizabeth</creatorcontrib><title>Task Force 1: The ACCF and AHA codes of conduct in human subjects research</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>Patients who participate in clinical trials, whether they receive experimental treatment or if they are in a control group, can benefit from meticulous attention to their care, by learning more about their disease process, and potentially, from the trial environment itself (6). Because results of research usually apply more directly to those patient groups included in the studies, it is especially important to include subjects from all socio-economic strata and all ethnic groups. In this setting, the potential for influence by factors unrelated to the best interest of the child, such as payment for participation, can significantly impact parental decision-making. [...]pediatric researchers are particularly obligated to strive for informed consent to the greatest extent possible.</description><subject>Advisory Committees</subject><subject>Bioethics</subject><subject>Cardiology</subject><subject>Cardiovascular Diseases - therapy</subject><subject>Clinical trials</subject><subject>Clinical Trials as Topic - legislation & jurisprudence</subject><subject>Codes</subject><subject>Conflict of Interest - legislation & jurisprudence</subject><subject>Ethics, Medical</subject><subject>Human Experimentation - legislation & jurisprudence</subject><subject>Human subjects</subject><subject>Humans</subject><subject>Informed consent</subject><subject>Informed Consent - legislation & jurisprudence</subject><subject>Mental Competency - legislation & jurisprudence</subject><subject>Participation</subject><subject>Pediatrics</subject><subject>Pharmaceutical industry</subject><subject>Research Design</subject><subject>Societies, Medical</subject><subject>Studies</subject><subject>Task forces</subject><subject>United States</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEGL1EAQhRtR3HH1D3iQBsFbYlU6ne4WL8PguCsLXsZz06muMIkzydo9Efz3ZpgBwcOe6h2-9yg-Id4ilAjYfBzKIRCVFUBdgi1B2WdihVrbQmlnnosVGKULBGduxKucBwBoLLqX4gZ1bR2iXolvu5B_yu2UiCV-krs9y_Vms5VhjHJ9t5Y0Rc5y6pYwxplOsh_lfj6GUea5HZhOWSbOHBLtX4sXXThkfnO9t-LH9stuc1c8fP96v1k_FKQsnApuFDpTVUjOtmjAhYYqq8EqBBXaaLSJXXDYGALbYaw7U6s2klJMRHWnbsWHy-5jmn7NnE_-2GfiwyGMPM3ZN40zTiMu4Pv_wGGa07j85lFDg3oxd6aqC0Vpyjlx5x9Tfwzpj0fwZ89-8GfP_uzZg_WL56X07jo9t0eO_ypXsQvw-QLwYuJ3z8ln6nkkjn1arPk49U_t_wW-T4q5</recordid><startdate>20041019</startdate><enddate>20041019</enddate><creator>Alpert, Joseph S.</creator><creator>Shine, Kenneth I.</creator><creator>Adams, Robert J.</creator><creator>Antman, Elliott M.</creator><creator>Kavey, Rae Ellen W.</creator><creator>Friedman, Lawrence</creator><creator>Frye, Robert L.</creator><creator>Harrington, Robert A.</creator><creator>Korn, David</creator><creator>Merz, Jon F.</creator><creator>Ofili, Elizabeth</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20041019</creationdate><title>Task Force 1: The ACCF and AHA codes of conduct in human subjects research</title><author>Alpert, Joseph S. ; Shine, Kenneth I. ; Adams, Robert J. ; Antman, Elliott M. ; Kavey, Rae Ellen W. ; Friedman, Lawrence ; Frye, Robert L. ; Harrington, Robert A. ; Korn, David ; Merz, Jon F. ; Ofili, Elizabeth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-e63197221c98b1709a6c285083103abd757dfa9167c08f1d4f743bdc33eccc4f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Advisory Committees</topic><topic>Bioethics</topic><topic>Cardiology</topic><topic>Cardiovascular Diseases - therapy</topic><topic>Clinical trials</topic><topic>Clinical Trials as Topic - legislation & jurisprudence</topic><topic>Codes</topic><topic>Conflict of Interest - legislation & jurisprudence</topic><topic>Ethics, Medical</topic><topic>Human Experimentation - legislation & jurisprudence</topic><topic>Human subjects</topic><topic>Humans</topic><topic>Informed consent</topic><topic>Informed Consent - legislation & jurisprudence</topic><topic>Mental Competency - legislation & jurisprudence</topic><topic>Participation</topic><topic>Pediatrics</topic><topic>Pharmaceutical industry</topic><topic>Research Design</topic><topic>Societies, Medical</topic><topic>Studies</topic><topic>Task forces</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alpert, Joseph S.</creatorcontrib><creatorcontrib>Shine, Kenneth I.</creatorcontrib><creatorcontrib>Adams, Robert J.</creatorcontrib><creatorcontrib>Antman, Elliott M.</creatorcontrib><creatorcontrib>Kavey, Rae Ellen W.</creatorcontrib><creatorcontrib>Friedman, Lawrence</creatorcontrib><creatorcontrib>Frye, Robert L.</creatorcontrib><creatorcontrib>Harrington, Robert A.</creatorcontrib><creatorcontrib>Korn, David</creatorcontrib><creatorcontrib>Merz, Jon F.</creatorcontrib><creatorcontrib>Ofili, Elizabeth</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alpert, Joseph S.</au><au>Shine, Kenneth I.</au><au>Adams, Robert J.</au><au>Antman, Elliott M.</au><au>Kavey, Rae Ellen W.</au><au>Friedman, Lawrence</au><au>Frye, Robert L.</au><au>Harrington, Robert A.</au><au>Korn, David</au><au>Merz, Jon F.</au><au>Ofili, Elizabeth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Task Force 1: The ACCF and AHA codes of conduct in human subjects research</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2004-10-19</date><risdate>2004</risdate><volume>44</volume><issue>8</issue><spage>1724</spage><epage>1728</epage><pages>1724-1728</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Patients who participate in clinical trials, whether they receive experimental treatment or if they are in a control group, can benefit from meticulous attention to their care, by learning more about their disease process, and potentially, from the trial environment itself (6). Because results of research usually apply more directly to those patient groups included in the studies, it is especially important to include subjects from all socio-economic strata and all ethnic groups. In this setting, the potential for influence by factors unrelated to the best interest of the child, such as payment for participation, can significantly impact parental decision-making. [...]pediatric researchers are particularly obligated to strive for informed consent to the greatest extent possible.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15489115</pmid><doi>10.1016/j.jacc.2004.08.038</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2004-10, Vol.44 (8), p.1724-1728 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_66979511 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ScienceDirect Journals (5 years ago - present); Alma/SFX Local Collection |
| subjects | Advisory Committees Bioethics Cardiology Cardiovascular Diseases - therapy Clinical trials Clinical Trials as Topic - legislation & jurisprudence Codes Conflict of Interest - legislation & jurisprudence Ethics, Medical Human Experimentation - legislation & jurisprudence Human subjects Humans Informed consent Informed Consent - legislation & jurisprudence Mental Competency - legislation & jurisprudence Participation Pediatrics Pharmaceutical industry Research Design Societies, Medical Studies Task forces United States |
| title | Task Force 1: The ACCF and AHA codes of conduct in human subjects research |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T19%3A25%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Task%20Force%201:%20The%20ACCF%20and%20AHA%20codes%20of%20conduct%20in%20human%20subjects%20research&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Alpert,%20Joseph%20S.&rft.date=2004-10-19&rft.volume=44&rft.issue=8&rft.spage=1724&rft.epage=1728&rft.pages=1724-1728&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2004.08.038&rft_dat=%3Cproquest_cross%3E3242521401%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1506152001&rft_id=info:pmid/15489115&rft_els_id=S0735109704017139&rfr_iscdi=true |